Literature DB >> 17265466

Neurobarrier coupling in the brain: adjusting glucose entry with demand.

Luc Leybaert1, Marijke De Bock, Marijke Van Moorhem, Elke Decrock, Elke De Vuyst.   

Abstract

Glucose transport over the blood-brain barrier (BBB) is a nonrate-limiting step and has therefore received little attention as a possible adjustment point within the transport reaction cascade from blood glucose to brain cell glycolysis. Considerations of the normal working point of facilitated BBB glucose shuttling via the GLUT-1 protein indicate that the transport is working at about one-third of T(max) under basal conditions. Substitution of T(max) estimates indicates that the transport is then just enough to keep up with glucose consumption, maintaining the steady state. After brain activation, glucose transport has to be stimulated, and this can be accomplished by increasing the driving force or changing the T(max) and/or K(t) parameters of BBB transport. The first possibility involves a decrease of brain interstitial glucose with subsequent flow stimulation according to the law of mass action (LMA), whereas the second possibility involves signaling from activated neurons to the BBB, a regulation loop that we propose to be called "neurobarrier coupling" (NBC). Theoretical analysis of the LMA effect and comparison with data on glucose dynamics during brain activation suggest that this factor alone only covers about half of the stimulation necessary to bring glucose delivery into line with the elevated glucose consumption during activation. Adjusting glucose entry with demand thus probably involves both LMA and NBC effects, depending on the degree of brain activation. Further work is needed to demonstrate NBC effects following physiological brain activation in vivo and to identify the signals that lead to NBC in in vitro experiments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265466     DOI: 10.1002/jnr.21189

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  20 in total

1.  Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors:  Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 2.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

3.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

Review 4.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

5.  SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect FA translocation.

Authors:  Anthony G Jay; Jeffrey R Simard; Nasi Huang; James A Hamilton
Journal:  J Lipid Res       Date:  2020-02-26       Impact factor: 5.922

6.  miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.

Authors:  Hongbao Guo; Yang Nan; Yingwei Zhen; Yahui Zhang; Liyun Guo; Kai Yu; Qiang Huang; Yue Zhong
Journal:  Tumour Biol       Date:  2016-07-31

Review 7.  Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2016-10-31

8.  The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma.

Authors:  Xiang Xu; Jiadi Xu; Linda Knutsson; Jing Liu; Huanling Liu; Yuguo Li; Bachchu Lal; John Laterra; Dmitri Artemov; Guanshu Liu; Peter C M van Zijl; Kannie W Y Chan
Journal:  Magn Reson Med       Date:  2019-02-22       Impact factor: 4.668

Review 9.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

10.  Sleep/wake dependent changes in cortical glucose concentrations.

Authors:  Michael B Dash; Michele Bellesi; Giulio Tononi; Chiara Cirelli
Journal:  J Neurochem       Date:  2012-11-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.